NDC 60219-2044-01 - dexamethasone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60219-2044
- Requested NDC
- 60219-2044-01
- Package NDCs from labels
- 60219-2044-1, 60219-2044-01
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-04-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone Tablets, USP (4 mg and 6 mg) Rx Only | Preferred Pharmaceuticals Inc. | 2026-04-01 | HUMAN PRESCRIPTION DRUG LABEL |
| dexamethasone - Major Pharmaceuticals | Major Pharmaceuticals | 2026-03-26 | HUMAN PRESCRIPTION DRUG LABEL |
| dexamethasone - RedPharm Drug, Inc | RedPharm Drug, Inc | 2024-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
| dexamethasone - Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals NY LLC | 2024-02-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60219-2044-1 | dexamethasone | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60219-2044 | DEXAMETHASONE TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 9 | Current NDC, Legacy NDC, 1 package rows | 20240717_ac71f888-c83a-46a5-921c-1ebdf6cfadc1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60219-2044-1 | EA - Each | 60219-2044 | edcd7bcc-8411-4ec8-ae73-27f4b19fa0c8 | 1 | 2021-11-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexamethasone | DEXAMETHASONE | Advanced Rx of Tennessee, LLC | 348f5a56-978d-4272-e063-6294a90afdb6 | 2025-05-07 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| MAXIDEX | DEXAMETHASONE | Harrow Eye, LLC | 35e47fcd-e020-43e5-8322-41f8060d220d | 2025-05-05 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Marlex Pharmaceuticals, Inc | 7b51ffce-ec64-4b49-8870-b9666537c541 | 2025-04-22 | Warnings, Adverse reactions | 7S5I7G3JQL |
| DEXTENZA | DEXAMETHASONE | Ocular Therapeutix, Inc. | 7514e6b8-c33f-4fbf-8810-ef520e1eb4bd | 2025-04-18 | Warnings, Adverse reactions | 7S5I7G3JQL |
| NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE SUSPENSION/ DROPS | DirectRx | d5e00bad-abb4-63ad-e053-2a95a90a5abb | 2025-04-15 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | Sandoz Inc | 05fd0c36-39b4-4a43-8490-eb8dfc0920ae | 2025-04-07 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Tobradex ST | TOBRAMYCIN / DEXAMETHASONE | Harrow Eye, LLC | 3b99dbb3-ac84-4d0d-b30f-a5db44fdc316 | 2025-04-01 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Proficient Rx LP | 3f2fe98a-ab42-4bec-bf97-c090567f9ad6 | 2025-04-01 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Bionpharma Inc., | 401ec088-984a-49ab-b317-747c2b9b9e22 | 2025-03-05 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Bionpharma Inc., | 3166db4f-66a5-496a-a194-3cc01b7347d3 | 2025-03-05 | Warnings, Adverse reactions | 197582 197583 7S5I7G3JQL |
| Ciprofloxacin and Dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | NuCare Pharmaceuticals, Inc. | 2f780550-ecbf-98fc-e063-6294a90a11c0 | 2025-03-03 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Sandoz Inc. | cf1a6da8-ba79-4bff-a13b-6effb67f6c1c | 2025-02-20 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals Inc. | b883860c-27ba-4bac-8ae3-4cf4d82d5071 | 2025-02-10 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | NuCare Pharmaceuticals,Inc. | b7b39ad5-e158-b8fe-e053-2995a90a5279 | 2025-02-07 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Prasco Laboratories | bfce6b49-f7ff-4ec7-9580-b730f0a207d7 | 2025-02-01 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Ciprofloxacin and Dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | Sandoz Inc | 89fef4d2-7078-47f1-96bf-aca50b135a97 | 2025-01-31 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Redpharm Drug, Inc. | 115e1bfb-1697-d567-e063-6394a90a78e5 | 2025-01-23 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | e90cb7f5-5e99-fbf3-e053-2995a90a70aa | 2025-01-22 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | fade983c-81fb-df94-e053-6394a90a7560 | 2025-01-22 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | 044d7898-4ab6-a0b3-e063-6294a90acdba | 2025-01-22 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.